Serena Williams says she has lost weight using GLP-1 medication. The drugs help manage blood sugar and promote weight loss, ...

Employers and benefits advisors are facing a growing challenge: How to offer access to these high-demand, life-changing ...

In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...

Last year, GLP-1s dominated many employer conversations as demand surged and pressure mounted from employees clamoring for ...

When the FDA took Novo Nordisk and Eli Lilly’s GLP-1 medications off of the drug shortage list, the move should have been a ...

GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, particularly in patients with type 2 diabetes, when combined with ...

SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher ...

GLP-1 patches for weight loss have made the scene—but a leading MD warns you they aren't the same as the more familiar prescriptions.

As appetite-suppressing drugs change the way people eat, businesses are adapting to GLP-1 users by offering smaller portions ...

Ro, the leading direct-to-patient healthcare company, today announced that Serena Williams—23-time Grand Slam champion, four-time Olympic gold medalist, and one of the most decorated athletes in ...

Insurance companies are increasingly restricting coverage for GLP-1 medications, impacting patient access and affordability.

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after 40 weeks ...